Trial Profile
Investigation of Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 15 Sep 2018 Status changed from recruiting to completed.
- 31 Jul 2018 Planned End Date changed from 31 Jul 2018 to 31 Jul 2019.
- 31 Jul 2018 Planned primary completion date changed from 21 Jul 2018 to 21 Jul 2019.